Compound ID | 2849
Class: Membrane-active agent
| Spectrum of activity: | Gram-negative |
| Details of activity: | Active against biofilm and planktonic Acinetobacter baumannii; dissipates proton motive force (membrane-active agent) |
| Description: | Decreases bacterial load and increases survival rate of mice infected with Acinetobacter baumannii when in combination with rifampicin; repurposed drug (approved for clinical use to inhibit overproduction of gastric acid); shows synergistic effects with rifampicin, ceftriaxone, gentamicin, and polymyxin B; shows intrinsic antimicrobial activity |
| Institute where first reported: | College of Animal Science and Technology, Jilin Agricultural University, Changchun, China |
| Year first mentioned: | 2023 |
| Development status: | Experimental |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/5702160 |
| Citation: | https://journals.asm.org/doi/10.1128/jb.00187-23 |